Research News

Research News Image

Long-Acting Injectable Antipsychotics Reduce Hospitalizations In Early Schizophrenia

Jul 15 2020
For individuals with schizophrenia who struggle to maintain regular treatment, long-acting injectable antipsychotics (LAIs) may be a valuable option. A new study indicates that LAIs may be especially beneficial as an early treatment. Among individuals who had been receiving antipsychotic therapy for fewer than five years, psychiatric hospitalization was less common for those treated with an LAI compared to typical treatment. Reducing the chances of relapse and hospitalization for those with early-phase schizophrenia is an important step to supporting recovery. To learn more, see the study in JAMA Psychiatry.